GALT icon

Galectin Therapeutics

61 hedge funds and large institutions have $20M invested in Galectin Therapeutics in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 12 closing their positions.

Holders
61
Holders Change
+1
Holders Change %
+1.67%
% of All Funds
1.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
15
Reduced
11
Closed
12
Calls
$1.3M
Puts
$2.12M
Net Calls
-$814K
Net Calls Change
+$255K
Name Holding Trade Value Shares
Change
Shares
Change %
SWM
51
SeaCrest Wealth Management
New York
$7K
BFEC
52
Benjamin F. Edwards & Company
Missouri
$5K +$5K +1,500 New
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$4K -$6.64K -1,825 -62%
NFG
54
Next Financial Group
Texas
$3K
Fidelity Investments
55
Fidelity Investments
Massachusetts
$3K
AF
56
Advisornet Financial
Minnesota
$3K +$3K +1,000 New
LTFS
57
Ladenburg Thalmann Financial Services
Florida
$3K +$3K +1,000 New
TWA
58
TCI Wealth Advisors
Arizona
$1K
RE
59
RBC Europe
United Kingdom
$137
Invesco
60
Invesco
Georgia
-$1.56M -259,463 Closed
Millennium Management
61
Millennium Management
New York
-$676K -112,399 Closed
BAM
62
Belpointe Asset Management
Nevada
-$187K -31,129 Closed
Squarepoint
63
Squarepoint
New York
-$177K -29,525 Closed
VF
64
Virtu Financial
New York
-$107K -17,752 Closed
HF
65
HRT Financial
New York
-$90K -15,050 Closed
HighTower Advisors
66
HighTower Advisors
Illinois
-$60K -9,905 Closed
TRCT
67
Tower Research Capital (TRC)
New York
-$51K -8,434 Closed
IP
68
Intellectus Partners
California
-$12K -2,000 Closed
PRS
69
Pinkerton Retirement Specialists
Idaho
-$6K -1,000 Closed
ASN
70
Advisory Services Network
Georgia
-$3K -500 Closed
CF
71
Centaurus Financial
California
-$60 -10 Closed